)
ResMed (RMD) investor relations material
ResMed 44th Annual J.P. Morgan Healthcare Conference summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Business performance and market overview
Achieved $5.3 billion in trailing 12-month revenue, with net operating profit margins above 30% and strong global distribution across 140 countries.
Software business, including Brightree and MEDIFOX DAN, represents 12% of revenue, expanding beyond hardware into healthcare solutions.
Strong cash flow of $1.8 billion in the last 12 months, supporting R&D, share buybacks, dividends, and M&A.
Maintained resilience through global crises, including COVID-19 and supply chain disruptions.
Large, underpenetrated markets in sleep and breathing health, with less than 20% of OSA patients diagnosed or treated in the US and under 10% globally.
Industry trends and innovation
Big Tech (Apple, Samsung, Oura, etc.) is integrating sleep apnea detection into wearables, expected to expand further by 2026.
Key megatrends such as digital health, wearables, and GLP-1 medications are increasing awareness and detection of sleep apnea.
AI-enabled devices and digital health tools, such as the AirTouch mask line and Dawn digital concierge, are enhancing patient adherence and experience.
Real-world evidence shows untreated sleep apnea increases mortality by 37%, with AI and digital tools supporting better outcomes.
Gamification and data access through apps like myAir drive patient engagement and adherence.
Strategic initiatives and ecosystem expansion
Acquisitions of Virtuox, Ectosense, and Somnoware strengthen home sleep apnea testing and software capabilities.
11 million patients use the myAir app, with 24 billion nights of medical data and 405 API calls per second in the ecosystem.
Education initiatives for primary care physicians have reached 60,000 CME downloads, with 77% planning to change protocols for sleep apnea management.
Targeting high-volume GLP-1 providers and expanding home testing access to streamline patient funnel.
Manufacturing expansion in the U.S. (Atlanta, Indianapolis) aligns with Made in America initiatives and doubles capacity.
Next ResMed earnings date
Next ResMed earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage
)
)